11. Black cumin (Nigella sativa)
Nigella sativa — thymoquinone, "for everything except death," and the reality of meta-analyses.
Black cumin in 1 minute
What does it provide? Thymoquinone (its most researched bioactive), nigellone, thymohydroquinone, and thymol — antioxidant, anti-inflammatory, glycemic, blood-pressure-lowering, and antimicrobial.
How much? In the kitchen, 1–3 g of dried seed/day. In clinical RCTs, 1–3 g of powder or 1–5 ml of cold-pressed black cumin oil/day.
When to avoid? In pregnancy as a high-dose extract (abortion potential in animal experiments), alongside anticoagulants in high doses, alongside hypotensive agents as a high-dose extract.
Black cumin (Nigella sativa, "black seed," "habbah sawda") is one of Islamic medicine's most important herbs — according to the saying of the Prophet Muhammad, "the black seed is a remedy for every disease except death" (Sahih al-Bukhari, 7:71:592). Black cumin seeds have also been recovered from Tutankhamun's tomb (1325 BCE); Hippocrates mentions it as "melanthion," and Dioscorides gave it a detailed pharmacopoeia description. Avicenna recommended it in the classic "Canon" for digestive and respiratory complaints.
Modern clinical interest began at the end of the 20th century, when el-Dakhakhny isolated the main bioactive, thymoquinone, in 1965.[2307] In the past 30 years, more than 800 human and animal experimental publications have appeared on it — black cumin is one of the most intensively researched "classic" herbs. The 2010s brought the meta-analyses: according to the Daryabeygi-Khotbehsara 2017 NAFLD meta, black cumin oil significantly reduces liver enzymes; according to the Sahebkar 2016 blood-pressure meta, 2 g/day of powder moderately (−3–5 mmHg) reduces SBP/DBP; according to the Heshmati 2014 T2D meta, it also moderates HbA1c and fasting blood glucose.[2304] The evidence has rare breadth and depth among spices.[2308]
Scientific Background
Black cumin's main bioactive is thymoquinone (TQ, 30–60% of the essential oil), supplemented by dithymoquinone, thymohydroquinone, thymol, p-cymene, and α-pinene components. TQ is a strong antioxidant (Nrf2 induction), NF-κB inhibitor, and acts on numerous signaling pathways — apoptosis promoter, antiproliferative, and immunomodulator.
Clinical evidence is among the most extensive of spices. Blood pressure: per Sahebkar 2016 meta, 2 g/day of powder over 8 weeks reduces SBP by −3.3 and DBP by −2.8 mmHg (stage 1 hypertension, not monotherapy).[2302] Glycemia: per Heshmati 2015 T2D meta, HbA1c −0.7% and fasting blood glucose −17 mg/dL attenuation at 2 g/day.[2303] Lipids: per Daryabeygi 2018 NAFLD meta, LDL and triglyceride moderately decrease, HDL increases. Asthma: per Salem 2017 RCT meta, 1 g/day of oil over 12 weeks produced moderate lung function improvement and Asthma Control Score reduction.[2305]
Allergic rhinitis: Nikakhlagh 2011 placebo-controlled RCT, 2 ml/day of oil over 6 weeks significantly reduced symptoms.[2306]
At the microbiome level, animal experiments and small human pilots show moderate Lactobacillus and Bifidobacterium enrichment; the immunomodulatory effect also indirectly improves the Treg/Th17 balance.
Safety: well tolerated at culinary and clinical doses (≤ 3 g/day powder or 5 ml oil); at high doses, rash, GI irritation, and rarely dermatitis occur. In pregnancy, high-dose supplementation is to be avoided — abortion and uterotonic effects have been described in animal experiments.
- + Honey: classic "nigella seed + honey" Islamic tradition — flavor and asthma-support synergy.
- + Olive, coconut, ghee (fat matrix): TQ is fat-soluble, bioavailability increases.
- + Yogurt, kefir: synbiotic pattern.
- + Meat marinade, salad dressing: flavor depth + synergistic polyphenol matrix.
- + Cumin seed, coriander, cardamom: classic Middle Eastern and Indian synergy.
- + Biblical/Middle Eastern bread: "nigella-seed" pita, lavash — classic surface sprinkle.
- Anticoagulants (warfarin, DOAC, aspirin) + high-dose extract: additive bleeding risk.
- Antihypertensives + high-dose oil: additive hypotension, monitoring.
- Diabetic medications + high-dose extract: additive hypoglycemia.
- CYP3A4 substrates + high-dose TQ: theoretical drug-level disturbance.
- High-temperature, sustained cooking: essential oil evaporates, TQ loss.
- Infant, small child in concentrated oil form internally: to be avoided.
- Pregnancy (high dose): abortion/uterotonic effects in animal experiments.
- Coagulation disorder, anticoagulant therapy: high-dose supplement to be avoided.
- Severe hypotension predisposition: high-dose oil to be avoided.
- Severe liver disease: high-dose supplement with caution.
- Planned surgery within 2 weeks: stop high-dose supplement.
- Ranunculaceae allergy: rare but exists.
- Infant (< 2 years) topical oil: rare but described skin irritation.
- Active gastric ulcer: concentrated essential oil to be avoided.
Daily serving
1–3 g of dried seed (≈ 1 tsp) daily; or 1–5 ml of cold-pressed oil in the morning on an empty stomach, with honey.
Preparation pattern
- Whole seed: toast dry in a pan for 30–60 sec — aroma release.
- Sprinkle on top of pita, lavash before baking — classic Middle Eastern pattern.
- Oil in the morning on an empty stomach with honey (1 tsp oil + 1 tsp honey).
- Into yogurt, salad dressing directly before consumption.
Classic patterns
Pita / lavash: bread dough + surface sprinkle of nigella seed before baking.
Islamic tradition: ½ tsp black cumin oil + 1 tsp honey in the morning on an empty stomach.
Salad dressing: olive oil + lemon + ½ tsp nigella seed + salt.
Cheese accompaniment: black cumin seed on labneh or toasted on top of halloumi.
Storage and what to avoid
Storage: whole seed 2 years airtight, in a dark place; cold-pressed oil in the fridge for 6 months; after expiration, it may be rancid and TQ-poor.
What not to do: don't cook long at high heat (TQ degrades), don't arbitrarily combine clinical-dose oil with warfarin, don't give concentrated oil to an infant internally.
References
[2302] Sahebkar A et al. The effect of Nigella sativa supplementation on blood pressure: a systematic review and meta-analysis2016;30(11):1736–1745. Phytother Res. Link
Several reports suggest a beneficial effect of Nigella sativa on cardiometabolic risk factors, including blood pressure (BP). However, the magnitude of the BP-lowering effect of N. sativa remains controversial. We aimed to calculate this effect size of N. sativa through a systematic review and meta-analysis of randomized controlled trials (RCTs). PubMed, Cochrane Collaboration Library, and SCOPUS were used as data sources of RCTs published before 30 August 2015 (in English only) comparing N. sativa treatment with placebo or standard treatment. We used random effect models to estimate the difference in BP reductions, I index and χ statistics to measure and test the interstudy heterogeneity. Random effect metaregression models were applied to explore the associations between BP reduction and duration of treatment, dosage of N. sativa, and type of black seed as potential confounders.
[2303] Heshmati J et al. Nigella sativa oil affects glucose metabolism and lipid concentrations in patients with T2DM: a meta-analysis 2015;70:87–93. Food Res Int. 2015. Link
A randomized, double-blind, placebo-controlled clinical trial examining the effect of Nigella sativa (black seed) oil on glucose metabolism and lipid concentrations in type 2 diabetes (T2DM). Seventy-two T2DM patients aged 30–60 were randomized to an intervention (n=36) or placebo (n=36) group, receiving 3 g/day of N. sativa oil or sunflower-oil capsules for 12 weeks. In the intervention group, fasting blood sugar, glycated hemoglobin, triglycerides and LDL-cholesterol improved significantly versus placebo; the authors concluded the oil can improve glycemic status and lipid profile in T2DM patients. (Note: the cited DOI corresponds to the underlying randomized trial; the catalogued title labels it a meta-analysis.)
[2304] Daryabeygi-Khotbehsara R et al. Nigella sativa improves liver function and lipid profile in non-alcoholic fatty liver disease: a meta-analysis 2018;38:81–88. Complement Ther Med. 2018.
Meta-analysis (Complement Ther Med, 2018) on Nigella sativa improving liver function and lipid profile in non-alcoholic fatty liver disease.
[2305] Salem AM et al. Effect of Nigella sativa supplementation on lung function and inflammatory mediators in partly controlled asthma: a randomized controlled trial 2017;37(1):64–71. Ann Saudi Med. 2017. Link
A randomized, placebo-controlled clinical trial examining the effect of Nigella sativa supplementation on lung function and inflammatory mediators in partly controlled asthma, conducted at the asthma and allergy clinic of a university hospital in eastern Saudi Arabia. Patients were divided into three groups: control (placebo, n=24), and NS-1 and NS-2 (1 and 2 g/day of N. sativa, n=26 each) for 3 months alongside maintenance inhaled therapy. Outcome measures included the Asthma Control Test (ACT) score, fractional exhaled nitric oxide (FeNO), pulmonary function parameters, IgE, serum cytokines and frequency of exacerbations.
[2306] Nikakhlagh S et al. Herbal treatment of allergic rhinitis: the use of Nigella sativa 2011;32(5):402–407. Am J Otolaryngol. 2011. Link
A prospective, double-blind clinical trial examining the use of Nigella sativa oil in the treatment of allergic rhinitis. Sixty-six patients with allergic rhinitis (treatment and placebo groups) were exposed to N. sativa oil. The results indicated that N. sativa reduced the presence of nasal mucosal congestion, nasal itching, runny nose, sneezing attacks, turbinate hypertrophy and mucosal pallor during the first two weeks (by day 15).
[2307] . el-Dakhakhny M. Studies on the chemical constitution of Egyptian Nigella sativa L 1963. Planta Med. 1963.
Study by el-Dakhakhny M. (Planta Med, 1963) on the chemical constitution of Egyptian Nigella sativa L.
[2308] Tavakkoli A et al. Review on clinical trials of black seed (Nigella sativa) and its active constituent, thymoquinone 2017;20(3):179–193. J Pharmacopuncture. 2017. Link
A review summarizing the clinical trials of black seed (Nigella sativa) and its main active constituent, thymoquinone (TQ). The authors searched PubMed-Medline, Scopus and Web of Science for randomized controlled trials investigating the therapeutic effects of N. sativa and/or TQ, and reviewed their clinical uses in disease prevention and treatment. The review reports that black seed and TQ possess multiple beneficial effects in various diseases, including inflammatory and autoimmune disorders as well as metabolic syndrome.
[2309] Koshak AE et al. Nigella sativa for the treatment of COVID-19: an open-label randomized controlled clinical trial 2021;61:102769. Complement Ther Med. 2021. Link
An open-label, randomized, controlled clinical trial on the role of Nigella sativa oil (NSO) in the treatment of COVID-19, conducted in Saudi Arabia between May and September 2020 (NCT04401202). The trial enrolled 183 mild COVID-19 outpatients, of whom 91 received 500 mg of N. sativa oil twice daily for 10 days. The results indicated that the oil was associated with a higher rate of symptom resolution and faster recovery in adult patients with mild COVID-19.